26th Jun 2007 08:00
International Medical Devices PLC26 June 2007 26th June 2007 International Medical Devices Plc ("IMD" or "the Company") Operational Update on Subsidiary Companies International Medical Devices Plc (AIM: INT), the fast-growing medical supplycompany, is pleased to announce an update of activities at its 100% ownedsubsidiaries Pro-Care Limited ("Pro-Care"), Response Medical Equipment Ltd("RME") and EMS Medical Ltd ("EMS"). In April 2007, Pro-Care signed an exclusive agreement with Primed Halberstadt, aGerman medical devices manufacturer, to supply wound drains throughout the UK byutilising their existing relationships with the National Health Service ("NHS")Supply Chain. The UK market for wound drains is estimated to be in the region of£5million p.a. and the Company believes that Pro-Care are able to secure asignificant market share over the next 18 months. Guy Mills, Director of Pro-Care, said, "Since the launch of the Primed range inApril 2007, sales have been above expectations. I am confident that, with theseproducts, we will be able to take a major share of the wound drain market in theUK." The Company also announces that the operations of two of its other subsidiarycompanies, Meddis Ltd and Minster Medical Ltd, have been successfully integratedinto the Acute Care Division of IMD which is headed by Pro-Care. Thisintegration strengthens Acute Care, particularly in the Suction and WoundDrainage where Pro-Care is now distributing some of the leading products in thecountry. Chris Thomas, CEO of IMD said: "The integration of Meddis and Minster intoPro-Care is in line with our strategy to build on four key areas - Acute Care,Aged Care, Cardiorespiratory and Medical Consumables. Our intention is to becomeone of the country's leading medical trading houses and we are pleased to reportthe continued progress at our Acute Care division." IMD's other wholly-owned subsidiaries, Response Medical Equipment Ltd and EMSMedical Ltd have now achieved ISO 13485:2003 certification. The accreditation isfor high-quality medical device development, manufacture and distribution withtechnical and administrative controls that ensure safety and reliabilityaccording to European regulatory and customer requirements. ISO 13485:2003 isglobally recognized as the most stringent standard of quality control formedical devices. Matt Root, Commercial Director at IMD, commented: "Our regulatory affairs teamhas worked extremely hard to achieve this accreditation in such a shorttimeframe. We are committed to delivering a particularly high quality of serviceto customers and suppliers alike, and it is gratifying to have received thirdparty endorsement of our quality management processes. We consider ISO 13485:2003 certification an important distinguishing factor and a major competitiveadvantage for the Company as we continue to achieve our strategic commercialobjectives." Ends For further information, contact: International Medical Devices JM Finn Parkgreen CommunicationsChris Thomas Geoff Nash Clare IrvineCEO +44 207 6289688 +44 207 851 7480+44 203 008 4960 Notes to Editors: International Medical Devices Plc is one of the UK's leading medical devicesupplier groups. It also owns significant distribution and technology rightsthroughout North America and most of Europe. The group was floated on AIM inNovember 2004 with the purpose of acquiring companies or businesses operating inthe health and medical devices sectors which have the prospect of deliveringhigh returns and significant capital growth. For further information on the Company and its subsidiaries, please visitwww.imd-plc.com This information is provided by RNS The company news service from the London Stock Exchange ENRelated Shares:
Intelliam Ai